HDO-antimiR

N/A

Report date: 2025/03/20 14:50:32
NME

Base Information

Drug NameHDO-antimiR
Drug Alias Namehetero duplex oligonucleotide-antimiRNA therapy (Tokyo Medical and Dental University)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTokyo Medical And Dental University
China Registration ClassN/A

Develop Information

Active CompaniesTokyo Medical And Dental University
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A